Atonco’s Post

MEET2WIN is also a unique opportunity to stimulate investment around innovation in the fight against #cancer! 💡 The OUI Investors (Oncology Upward Investment) session offers 10 startups the chance to pitch their project to a large panel of European investors likely to support their growth.📈 ➡️ Info & registration: www.meet2win.fr An event MATWIN Unicancer #innovation #oncology #investement 👏 Congratulations to the shortlisted companies - Coralie Dorard, Actipulse Neuroscience® - Michael Heim, Altevax Biotech - Sylvain Fanier, Atonco - Valerie Taly, METHYS Dx - Samuel Sánchez Ordóñez, Nanobots Therapeutics - Claudia Scheckel, Oncobit AG - Alexandre Hill, Serendip innovations - Georges Rawadi, Stromacare SAS - Joseph ANDRÉ, TheraSonic - Camille Granet, Yomi Pharma